Startup Stage - Fintech, Payment, Anti-Fraud & InsurTech - Presentation by Claudia Lang, Co-Founder of Community Life at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Local Deliveries & Logistics - Presentation by Griselda Miralles, Co-Founder of DATALONG16 at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Gaming, Education & Media - Presentation by Gaelle Madelin-Girardeau, Co-Founder & CEO of COOD at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Startup Stage - Travel - Presentation by Maximilian Waldmann, Founder & CEO of conichi at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Business Productivity Tools - Presentation by Sergio Esteve de Miguel, Co-Founder & CMO of Bigle Legal at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
B2B & Software - Company Presentation by Nicolas Witte, CEO of Control€xpert at the Axel Springer NOAH Conference 2018 in Berlin, Tempodrom 6-7 June 2018.
Startup Stage - Business Productivity Tools - Presentation by Tomas Gogar, Founder of Rossum at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Gaming, Education & Media - Presentation by Benjamin Föckersperger, Co-Founder of Esports.com at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Startup Stage - Fintech, Payment, Anti-Fraud & InsurTech - Presentation by Claudia Lang, Co-Founder of Community Life at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Local Deliveries & Logistics - Presentation by Griselda Miralles, Co-Founder of DATALONG16 at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Gaming, Education & Media - Presentation by Gaelle Madelin-Girardeau, Co-Founder & CEO of COOD at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Startup Stage - Travel - Presentation by Maximilian Waldmann, Founder & CEO of conichi at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Business Productivity Tools - Presentation by Sergio Esteve de Miguel, Co-Founder & CMO of Bigle Legal at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
B2B & Software - Company Presentation by Nicolas Witte, CEO of Control€xpert at the Axel Springer NOAH Conference 2018 in Berlin, Tempodrom 6-7 June 2018.
Startup Stage - Business Productivity Tools - Presentation by Tomas Gogar, Founder of Rossum at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Gaming, Education & Media - Presentation by Benjamin Föckersperger, Co-Founder of Esports.com at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Startup Stage - Travel - Presentation by Mateusz Sewastynowicz, Founder & CEO and Waleria Pekalska, Marketplace Manager of TRIPSOMNIA at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - MedTech - Presentation by Ian Harris, CEO of Brainminer at the NOAH Conference London 2016, Old Billingsgate on the 11th of November 2016.
Startup Stage - Fintech, Payment, Anti-Fraud & InsurTech - Presentation by Steve Emecz, CCO of collectAI at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Company Presentation by Peter Bakenecker, Division President Germany & Switzerland at Mastercard at the Axel Springer NOAH Conference 2018 in Berlin, Tempodrom 6-7 June 2018.
Company Pitch by Ann-Sophie Claus & Sinja Stadelmaier, The Female Company at the Axel Springer NOAH Conference 2018 in Berlin, Tempodrom 6-7 June 2018.
Zebra Medical Vision - NOAH18 Tel Aviv NOAH Advisors
Artificial Intelligence & Deep Learning - Presentation by Elad Benjamin, Co-Founder & CEO of Zebra Medical Vision at the NOAH Conference Tel Aviv 2018, Haoman 17 on the 14th of March 2018.
Startup Stage - Marketing Technology - Presentation by Jean-Chris Lesbros, CEO of Rich Audience at the NOAH Conference London 2017, Old Billingsgate on the 2nd of November 2017.
Startup Stage - Mobility & Navigation - Presentation by Annina Koskiola, Co-Founder & CEO of Proximi.io at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Artificial Intelligence & Deep Learning - Presentation by Ira Cohen, Co-Founder of Anodot at the NOAH Conference Tel Aviv 2018, Haoman 17 on the 14th of March 2018.
Fintech - Presentation by Dr. Julian Hosp, Co-Founder & President of TenX at the NOAH Conference London 2017, Old Billingsgate on the 3rd of November 2017.
Official speaker book for the NOAH 2019 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
Official speaker book for the NOAH 2018 Conference in Tel Aviv with comprehensive background information on all presenting speakers and their companies.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
2. Three Conferences, One Mission: Empower the European Digital Ecosystem
To provide a physical marketplace
that facilitates funding of
digital European companies
at all stages
Mission MissionMission
To promote Israel - European
relationships and enable funding
To bring together future-shaping
executives and investors active
across segments driven
by digital revolution
Connecting
Capital with
Entrepreneurs
Connecting European
Champions
and Challengers
Connecting Israel’s Startups
with Large Corporates
and Investors
30-31 October 2018
Old Billingsgate, London
13-14 June 2019
STATION Berlin
9-10 April 2019
Haoman 17, Tel Aviv
3. Skin cancer is the fastest growing type of
cancer worldwide
Magnosco NOAH Presentation
Every
54 minutes
one person dies
of melanoma.
22.000
European
citizens lose
their lives to
the disease.
440.000
suspicious lesions
are excised in
Germany
each year.
227.05.18
4. Addressable market is worth € 2.9 bn
• Annual cost of treating skin cancer
estimated at $ 8.1 bn in the US alone
• Melanoma market annual growth by
6-12%
3Magnosco NOAH Presentation
.
27.05.1827.05.18
5. The problem: skin cancer screening is
time-consuming and biopsi-heavy
4Magnosco NOAH Presentation
Result
after ~14
days
Identification Biopsie
Histological
findings of the
skin sample
Only in
1-3 %
confirmed.
*
Source: https://www.researchgate.net/
publication/
5663596_Melanoma_diagnosis_Austral
ian_dermatologists%27_number_need
ed_to_treat
*Helfand M. et al: Screening for skin
cancer. Am J Prev Med. 20, 47-58
(2001)
27.05.18
6. The solution: magnosco DermaFC non-
invasive melanoma diagnostics
*as of Q4 2018
1-5
minutes.*
Doctor identifies
suspicious lesions
Diagnosis
(recommendation)
Scanning with
DermaFC
27.05.18 Magnosco NOAH Presentation 5
8. The CE-certified medical product makes
malignant cells visible
7Magnosco NOAH Presentation
Melanoma Healthy Tissue
27.05.18
objective, physical method * early detection * immediate visual result & score
9. Go-to-market in Germany: 130 Mio €
spent on skin cancer screening
8Magnosco NOAH Presentation
skin
cancer
screening
qualified
physicians
Potential market
Source_ Zentrum für Krebsregisterdaten
*2016 in Germany/ Bundesärztekammer
27.05.18
10. Adressing KOLs with installation fee &
payPerUse
9
Calculation of customer benefits/ additional
revenue for doctors
Revenue
for Clinics
up to
250k €
per year
Examinations
with DermaFC
per month
Price per
examination
licence for
magnosco Income clinic month
Share magnosco/
month
300 98,7 € 29,7 € 20.700,0 € 8.910,0 €
200 98,7 € 29,7 € 13.800,0 € 5.940,0 €
100 98,7 € 29,7 € 6.900,0 € 2.970,0 €
50 98,7 € 29,7 € 3.450,0 € 1.485,0 €
• Class 2A medical device approved for diagnostic support
of malignant melanoma
• Use in suspected melanoma, alternative to excision
• Billing via fee regulations doctors or as a self-payer
payment (“IGEL-Leistung”)
27.05.18 Magnosco NOAH Presentation
11. Trusted customers and partners
1027.05.18 Magnosco NOAH Presentation
u Key opinion leaders
at Germany’s leading
dermatology clinics
u Manufacturing
Partners
u Software
Developmemt
Partner
u AOK-Nordost
u Research & Science
Partners
u Regulatory affairs partner
Customers (prospect)
Partners
u User Experience/
Usability Partner
u PR Partner
12. Outlook: Further development in 2019
1127.05.18 Magnosco NOAH Presentation
magnosco
screening App
in vivo DermaFC
2.0
ex vivo HistoFC
13. Outlook: No1 partner for skin cancer
screening
1227.05.18 Magnosco NOAH Presentation
HistoFC
• ex-vivo
• diagnostics for
labratories
self documenting
lesions
DermaFC App (patient)
DermaFC App (clinic)
documenting lesions
in high resolution over
longer periods
DermaFC 2.0
• small hand-device
in-vivo SCS
Creating awareness,
patient acquisition &
retention
Info-channels
Patient
Clinic
14. Team experienced in building successful
companies & medical device sales
1321.05.18 Magnosco NOAH Presentation27.05.18
15. Investment Facts
• Funding received 5,5 Million €
• Volume: 10 Million €
• Duration: 2-3 years
• Structure: German GmbH
Use of proceeds: Go-to-market, new
product development
1427.05.18 Magnosco NOAH Presentation
17. Selected Completed NOAH Transactions
Focus on Leading European Internet companies
Covering over 400 companies across 25 online
verticals, a broad range of over 500 investors as
well as 100+ online-focused corporates
Deep understanding of industry dynamics
Ability to add value beyond banking advice
Facilitates overall process and minimizes
management distraction
NOAH Advisors is globally well connected
and has direct access to virtually all key
players in the industry
Knowledge of and strong relationships with
potential buyers’ key decision makers
Proactively finds and unlocks attractive
investment opportunities for leading investors
Annual NOAH Conference in its 8th year
Over 40 years of combined relevant M&A experience
Routine execution of M&A and financing transactions
with sizes of several billion euros
30 successfully completed NOAH Advisors transactions
underline successful transfer of M&A competencies to
the Internet sector
Entrepreneurial mind-set, focused on growing the
business and establishing a reputation for excellence
Ability to deliver top results in short time frames
Highly success-based compensation structures align
interests of clients and NOAH Advisors, and demonstrate
conviction to deliver top results
Creative deal solutions
December 2014
September 2014
October 2014
May 2014
Sale of 100% of
for $800m to
Exclusive Financial Advisor to
Fotolia and the Selling Shareholders
Sale of 100% of
for €80m to
Exclusive Financial Advisor to
Trovit and its Shareholders
Sale of controlling stake in
to
Exclusive Financial Advisor to
Facile.it and its Shareholders
sold 100% of
for $228m to a joint venture between
Exclusive Financial Advisor to Yad2
and its Shareholders
Unique Industry Know-How
Unmatched Network and Relationships
Strong Investment Banking Competence
Full Commitment - We Are Entrepreneurs!
EUROPE’S LEADING INTERNET
CORPORATE FINANCE BOUTIQUE
September 2016October 2016
December 2016
Financial Advisor to Oakley Capital
®
Marco Rodzynek
Managing Director & Founder
marco.rodzynek@noah-advisors.com
Jan Brandes
Managing Director
jan.brandes@noah-advisors.com
The NOAH Advisors Core Banking Team
Acquisition of a Majority Stake in
by
from
at a valuation of €300m
Investment in
Exclusive Financial Advisor to KäuferPortal
and its Shareholders
by
84% Ownership
Financial Advisor to Silver Lake
Investment in
by
August 2017
Financial Advisor to EMK Capital
Acquisition of a Majority Stake in
by
at a valuation of $200m
Aleksander Skwarczek
Analyst
aleksander.skwarczek@noah-advisors.com
Nikhil Parmar
Director
nikhil.parmar@noah-advisors.com